$BEAT News

HeartBeam Announces New Peer-Reviewed Article Demonstrating Potential to Help Identify Heart Attack Risk at Home

HeartBeam Publishes JACC Study Showing Its Credit Card‑Sized ECG Device Can Predict Heart Attack Risk In Chest Pain Patients

HC Wainwright & Co. Maintains Buy on HeartBeam, Lowers Price Target to $2.5

Benchmark Maintains Speculative Buy on HeartBeam, Lowers Price Target to $5

HeartBeam (BEAT) Advances Commercial Launch, Reports First-Quarter 2026 Results

HeartBeam, Inc. Q1 2026 Earnings Call Summary

HeartBeam Inc (BEAT) Q1 2026 Earnings Call Highlights: Strategic Partnerships and Financial ...

HeartBeam Q1 2026 Earnings Call: Complete Transcript

HeartBeam Reports First Quarter 2026 Results

HeartBeam, Inc. 2026 Q1 - Results - Earnings Call Presentation

HeartBeam Q1 2026 Earnings Call: Complete Transcript

HeartBeam Q1 EPS $(0.12) Beats $(0.14) Estimate

HeartBeam (BEAT) Launches Pilot Study for On-Demand 12-Lead ECG Patch in Coronary Artery Disease Patients

HeartBeam Initiates Pilot Study of First On-Demand 12-Lead ECG Patch to Detect Ischemia Outside the Clinic

HeartBeam Initiates Pilot Study Of Its Novel 12-Lead ECG Patch In Patients With Suspected Coronary Artery Disease

HeartBeam (BEAT) Expands Concierge Cardiology Footprint With Atelier Health Agreement

HeartBeam Expands Commercial Presence Across Four Key U.S. Markets with Addition of Premier Concierge Practice

HeartBeam Enters Commercial Agreement With Atelier Health To Expand The Company's Commercial Footprint Across Four Targeted Launch Markets

HeartBeam (BEAT) Tackles Heart Disease With Next-Generation ECG Solutions

HeartBeam (BEAT) to Host Q1 2026 Earnings Call and Provide Strategic Updates